At Fortis Memorial Research Institute, Uterine Cancer Treatment is provided through personalized cancer treatment plans supported by experienced specialists and advanced diagnostic technology. Established in 2013, the JCI, NABH, NABL accredited hospital in Gurgaon, India has 311 beds and offers comprehensive gynecologic oncology services.

Uterine Cancer Treatment is selected according to the cancer's histological type, stage, grade, and molecular characteristics. For many patients, surgery may be the primary treatment, while radiation therapy or systemic medicines may be recommended based on the risk of recurrence or spread. Advanced disease may require combinations of chemotherapy, hormone therapy, targeted medicines, or immunotherapy. Regular imaging and clinical assessments help evaluate treatment response and monitor for recurrence.